Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Proto Labs IncPRLB · Entity 4553 | Chief Technology Officer | February 15, 2022 | February 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Proto Labs Inc
Report date February 15, 2022 · Filed February 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,695 |
Reported balance
After 2022-02-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-02-15 · Grant · Acquired 5,893 · Balance 36,695 F1: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. F2: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 188 shares purchased on May 15, 2021 and 1 share purchased on November 15, 2021 through the issuer's Employee Stock Purchase Plan program. |
| Common StockSEC Table I · non-derivative | Direct | 35,307 |
Reported balance
After 2022-02-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-02-17 · Tax withholding · Disposed 1,388 · Balance 35,307 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.40 · Expires 2032-02-13 | Direct | 6,287 |
Reported balance
After 2022-02-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-15 · Grant · Acquired 6,287 · Balance 6,287 F3: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Expires 2024-12-31 | Direct | 2,947 |
Reported balance
After 2022-02-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-15 · Grant · Acquired 2,947 · Balance 2,947 F4: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested.
F2: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 188 shares purchased on May 15, 2021 and 1 share purchased on November 15, 2021 through the issuer's Employee Stock Purchase Plan program.
F3: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested.
F4: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2022 Filed Feb 17, 2022 21:07 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 1,388 | $56.34 | $78,199.92 |
DisclosureSEC source: 0001437749-22-003677 · rdgdoc.xml · nonDerivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,307 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantPerformance Stock Units · Derivative | 2,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003677 · rdgdoc.xml · derivative · entry 4 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,947 Underlying: Common Stock · 2,947 shares Expires 2024-12-31 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 6,287 | $0.00 Strike: $59.40 | $0.00 |
DisclosureSEC source: 0001437749-22-003677 · rdgdoc.xml · derivative · entry 3 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,287 Underlying: Common Stock · 6,287 shares Expires 2032-02-13 F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 5,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003677 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,695 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 188 shares purchased on May 15, 2021 and 1 share purchased on November 15, 2021 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| December 01, 2021 Filed Dec 1, 2021 19:55 UTC | Proto Labs Inc PRLB · Entity 4553 | PurchaseCommon Stock | 10,000 | $49.21 | $492,100.00 |
DisclosureSEC source: 0001437749-21-027612 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,613 Read SEC document |
| May 04, 2021 Filed May 6, 2021 14:59 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 375 | $102.75 | $38,531.25 |
DisclosureSEC source: 0001437749-21-011051 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,613 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,442 | $0.00 Strike: $180.46 | $0.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · derivative · entry 14 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,442 Underlying: Common Stock · 3,442 shares Expires 2031-02-16 F10 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,628 | $0.00 Strike: $58.35 | $0.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · derivative · entry 13 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 907 Underlying: Common Stock · 3,628 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2018. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,474 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · derivative · entry 12 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,737 Underlying: Common Stock · 3,474 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on May 4, 2017. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 4,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 11 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,988 F9 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 1,087 | $197.05 | $214,193.35 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 10 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,776 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 2,000 | $196.26 | $392,520.00 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 9 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,863 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 700 | $186.82 | $130,774.77 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 8 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,863 F6 · price: Reflects the weighted average price of 700 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $186.43 to $187.34 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 2,100 | $185.66 | $389,887.47 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 7 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,563 F5 · price: Reflects the weighted average price of 2,100 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $185.37 to $186.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,500 | $184.85 | $277,275.45 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 6 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,663 F4 · price: Reflects the weighted average price of 1,500 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $184.35 to $185.33 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 900 | $183.69 | $165,318.12 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 5 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,163 F3 · price: Reflects the weighted average price of 900 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $183.34 to $184.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,100 | $182.81 | $201,093.31 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 4 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,063 F2 · price: Reflects the weighted average price of 1,100 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $182.19 to $183.17 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 802 | $181.09 | $145,235.46 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 3 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,163 F1 · price: Reflects the weighted average price of 802 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $180.85 to $181.76 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 3,628 | $58.35 | $211,693.80 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 3,474 | $60.96 | $211,775.04 |
DisclosureSEC source: 0001437749-21-003290 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2020 Filed May 20, 2020 21:07 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,988 | $115.07 | $228,751.21 |
DisclosureSEC source: 0001437749-20-011432 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,863 F1 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 258 shares purchased on May 15, 2020 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:22 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 252 | $94.22 | $23,743.44 |
DisclosureSEC source: 0001437749-20-009601 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,593 Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:24 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 838 | $100.00 | $83,800.00 |
DisclosureSEC source: 0001437749-20-002920 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,845 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:30 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,668 | $0.00 Strike: $96.72 | $0.00 |
DisclosureSEC source: 0001437749-20-002460 · rdgdoc.xml · derivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,668 Underlying: Common Stock · 3,668 shares Expires 2030-02-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:30 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 3,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002460 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,683 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2021. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 291 shares purchased on May 15, 2018, 197 shares purchased on May 15, 2019, and 1 share purchased on November 15, 2019 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| May 04, 2019 Filed May 7, 2019 20:44 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 252 | $110.55 | $27,858.60 |
DisclosureSEC source: 0001437749-19-009002 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,123 Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:08 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,204 | $0.00 Strike: $104.99 | $0.00 |
DisclosureSEC source: 0001437749-19-002463 · rdgdoc.xml · derivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,204 Underlying: Common Stock · 3,204 shares Expires 2029-02-11 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:08 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 2,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-002463 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,375 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| September 04, 2018 Filed Sep 11, 2018 19:46 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,474 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001437749-18-016849 · rdgdoc.xml · derivative · entry 3 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,211 Underlying: Common Stock · 3,474 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on May 4, 2017. Read SEC document |
| September 04, 2018 Filed Sep 11, 2018 19:46 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 3,474 | $154.81 | $537,815.15 |
DisclosureSEC source: 0001437749-18-016849 · rdgdoc.xml · nonDerivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,546 F1 · price: Reflects the weighted average price of 3,474 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 4, 2018 with sale prices ranging from $154.55 to $155.10 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 04, 2018 Filed Sep 11, 2018 19:46 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 3,474 | $60.96 | $211,775.04 |
DisclosureSEC source: 0001437749-18-016849 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 21:23 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 394 | $106.45 | $41,941.30 |
DisclosureSEC source: 0001437749-18-002789 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,820 Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:47 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,218 | $0.00 Strike: $105.75 | $0.00 |
DisclosureSEC source: 0001437749-18-002613 · rdgdoc.xml · derivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Underlying: Common Stock · 3,218 shares Expires 2028-02-12 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2019. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:47 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 2,809 | $105.75 | $297,051.75 |
DisclosureSEC source: 0001437749-18-002613 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,214 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2019. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person as of February 14, 2018, including a total of 870 shares of Common Stock of the issuer purchased by the reporting person through the issuer's Employee Stock Purchase Plan program on May 15, 2017 and November 15, 2017. Read SEC document |
| May 08, 2017 Filed Mar 26, 2018 20:25 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 274 | $59.75 | $16,371.50 |
DisclosureSEC source: 0001437749-18-005465 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,546 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:00 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 4,535 | $0.00 Strike: $58.35 | $0.00 |
DisclosureSEC source: 0001437749-17-002567 · rdgdoc.xml · derivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,535 Underlying: Common Stock · 4,535 shares Expires 2027-02-13 F2 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2018. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:00 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 6,430 | $58.35 | $375,190.50 |
DisclosureSEC source: 0001437749-17-002567 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,535 F1 · shares: The restricted stock units vest as to 20% of the shares in five annual installments beginning on February 13, 2018. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:32 UTC | Proto Labs Inc PRLB · Entity 4553 | PurchaseCommon Stock | 3,000 | $55.00 | $165,000.00 |
DisclosureSEC source: 0001437749-16-038348 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,105 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.